BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33666941)

  • 1. Location of recurrent cardiovascular events and anticardiolipin antibodies.
    Galán-González J; Rico-Martín S; Calderón-García JF; Antón J; Ramírez-Moreno JM; Álvarez-Rodríguez LR; Sánchez Muñoz-Torrero JF;
    Eur J Clin Invest; 2021 Jul; 51(7):e13533. PubMed ID: 33666941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients. Thrombogenic Factors, and Recurrent Coronary Events Investigators.
    Bili A; Moss AJ; Francis CW; Zareba W; Watelet LF; Sanz I
    Circulation; 2000 Sep; 102(11):1258-63. PubMed ID: 10982540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome in patients with peripheral artery disease. Results from a prospective registry (FRENA).
    Monreal M; Alvarez L; Vilaseca B; Coll R; Suárez C; Toril J; Sanclemente C;
    Eur J Intern Med; 2008 May; 19(3):192-7. PubMed ID: 18395163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking cessation and outcome in stable outpatients with coronary, cerebrovascular, or peripheral artery disease.
    Alvarez LR; Balibrea JM; Suriñach JM; Coll R; Pascual MT; Toril J; López-Jiménez L; Monreal M;
    Eur J Prev Cardiol; 2013 Jun; 20(3):486-95. PubMed ID: 21968571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome of stable outpatients with coronary, cerebrovascular or peripheral artery disease, and atrial fibrillation.
    Aguilar E; García-Díaz AM; Sánchez Muñoz-Torrero JF; Alvarez LR; Piedecausa M; Arnedo G; Monreal M;
    Thromb Res; 2012 Sep; 130(3):390-5. PubMed ID: 22658293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticardiolipin antibodies and the risk of recurrent thrombo-occlusive events and death. The Antiphospholipid Antibodies and Stroke Study Group (APASS).
    Neurology; 1997 Jan; 48(1):91-4. PubMed ID: 9008500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose control and outcome in patients with stable diabetes and previous coronary, cerebrovascular or peripheral artery disease. Findings from the FRENA Registry.
    Camafort M; Alvarez-Rodríguez LR; Muñoz-Torrero JF; Sahuquillo JC; López-Jiménez L; Coll R; Monreal M;
    Diabet Med; 2011 Jan; 28(1):73-80. PubMed ID: 21166848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function and short-term outcome in stable outpatients with coronary, cerebrovascular or peripheral artery disease.
    Bernaudo D; Coll R; Sánchez Muñoz-Torrero JF; Pascual MT; García-Díaz AM; Alvarez LR; Monreal M;
    Atherosclerosis; 2013 Jul; 229(1):258-62. PubMed ID: 23714334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol consumption and outcome in stable outpatients with peripheral artery disease.
    Garcia-Diaz AM; Marchena PJ; Toril J; Arnedo G; Muñoz-Torrero JF; Yeste M; Aguilar E; Monreal M;
    J Vasc Surg; 2011 Oct; 54(4):1081-7. PubMed ID: 21684714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticardiolipin antibodies as an independent risk factor for stroke in young Saudis.
    Daif AK
    Funct Neurol; 1998; 13(4):285-9. PubMed ID: 9934572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin G (IgG) anticardiolipin antibodies and recurrent cardiovascular events. A systematic review and Bayesian meta-regression analysis.
    Pastori D; Bucci T; Triggiani M; Ames PRJ; Parrotto S; Violi F; Pignatelli P; Farcomeni A
    Autoimmun Rev; 2019 May; 18(5):519-525. PubMed ID: 30844560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticardiolipin antibody and anti-β2 glycoprotein I antibody are potential risk markers of ischaemic stroke in Chinese adults.
    Dong S; Pei B; Xie W; Wang J; Zeng Q
    Rheumatology (Oxford); 2020 Aug; 59(8):1834-1841. PubMed ID: 31722435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity, isotype, and titer distribution of anticardiolipin antibodies in CNS diseases.
    D'Olhaberriague L; Levine SR; Salowich-Palm L; Tanne D; Sawaya KL; Aurora TK; Perry M; Day M; Spencer T; Schultz L
    Neurology; 1998 Nov; 51(5):1376-80. PubMed ID: 9818863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors and risk for recurrent ischemic events or death in outpatients with symptomatic artery disease.
    Muñoz-Torrero JFS; Zamorano J; Rico-Martín S; Rivas MD; Bacaicoa MA; Robles R; Sanchez-Bacaicoa C; Monreal M;
    Atherosclerosis; 2020 Jan; 292():84-89. PubMed ID: 31785493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between anticardiolipin antibodies and mortality in patients with peripheral arterial disease.
    Puisieux F; de Groote P; Masy E; Di Pompeo C; Millaire A; Bouillanne O; Jude B; Dewailly P; Ducloux G
    Am J Med; 2000 Dec; 109(8):635-41. PubMed ID: 11099683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein (a) levels and outcomes in stable outpatients with symptomatic artery disease.
    Sanchez Muñoz-Torrero JF; Rico-Martín S; Álvarez LR; Aguilar E; Alcalá JN; Monreal M;
    Atherosclerosis; 2018 Sep; 276():10-14. PubMed ID: 30006322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systolic Blood Pressure and Outcomes in Stable Outpatients with Recent Symptomatic Artery Disease: A Population-Based Longitudinal Study.
    Sánchez Muñoz-Torrero JF; Escudero-Sánchez G; Calderón-García JF; Rico-Martín S; Robles NR; Bacaicoa MA; Alcalá-Pedrajas JN; Gil-Fernández G; Monreal M; On Behalf Of The Frena Investigators
    Int J Environ Res Public Health; 2021 Sep; 18(17):. PubMed ID: 34501937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between anticardiolipin antibodies and recurrent cardiac events in patients with acute coronary syndrome.
    Gürlek A; Ozdöl C; Pamir G; Dinçer I; Tutkak H; Oral D
    Int Heart J; 2005 Jul; 46(4):631-8. PubMed ID: 16157954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial.
    Gutierrez JA; Mulder H; Jones WS; Rockhold FW; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Held P; Katona BG; Mahaffey KW; Norgren L; Hiatt WR; Patel MR
    JAMA Netw Open; 2018 Nov; 1(7):e185239. PubMed ID: 30646395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anticardiolopin antibodies as a risk factor in stroke].
    Krześniak-Bohdan M; Dobrzyńska L; Bakowska A; Banecka-Majkutewicz Z
    Wiad Lek; 1998; 51(9-10):414-8. PubMed ID: 9921104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.